Literature DB >> 26487421

The importance of neuronal growth factors in the ovary.

S Streiter1, B Fisch2, B Sabbah3, A Ao4, R Abir5.   

Abstract

The neurotrophin family consists of nerve growth factor (NGF), neurotrophin 3 (NT3) and neurotrophin 4/5 (NT4/5), in addition to brain-derived neurotrophic factor (BDNF) and the neuronal growth factors, glial cell line-derived neurotrophic factor (GDNF) and vasointestinal peptide (VIP). Although there are a few literature reviews, mainly of animal studies, on the importance of neurotrophins in the ovary, we aimed to provide a complete review of neurotrophins as well as neuronal growth factors and their important roles in normal and pathological processes in the ovary. Follicular assembly is probably stimulated by complementary effects of NGF, NT4/5 and BDNF and their receptors. The neurotrophins, GDNF and VIP and their receptors have all been identified in preantral and antral follicles of mammalian species, including humans. Transgenic mice with mutations in the genes encoding for Ngf, Nt4/5 and Bdnf and their tropomyosin-related kinase β receptor showed a reduction in preantral follicles and an abnormal ovarian morphology, whereas NGF, NT3, GDNF and VIP increased the in vitro activation of primordial follicles in rats and goats. Additionally, NGF, NT3 and GDNF promoted follicular cell proliferation; NGF, BDNF and VIP were shown to be involved in ovulation; VIP inhibited follicular apoptosis; NT4/5, BDNF and GDNF promoted oocyte maturation and NGF, NT3 and VIP stimulated steroidogenesis. NGF may also exert a stimulatory effect in ovarian cancer and polycystic ovarian syndrome (PCOS). Low levels of NGF and BDNF in follicular fluid may be associated with diminished ovarian reserve and high levels with endometriosis. More knowledge of the roles of neuronal growth factors in the ovary has important implications for the development of new therapeutic drugs (such as anti-NGF agents) for ovarian cancer and PCOS as well as various infertility problems, warranting further research.
© The Author 2015. Published by Oxford University Press on behalf of the European Society of Human Reproduction and Embryology. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  GDNF; VIP; neuronal growth factor receptors; neurotrophins; ovary

Mesh:

Substances:

Year:  2015        PMID: 26487421     DOI: 10.1093/molehr/gav057

Source DB:  PubMed          Journal:  Mol Hum Reprod        ISSN: 1360-9947            Impact factor:   4.025


  23 in total

1.  Innervation of cervical carcinoma is mediated by cancer-derived exosomes.

Authors:  Christopher T Lucido; Emily Wynja; Marianna Madeo; Caitlin S Williamson; Lauren E Schwartz; Brittney A Imblum; Ronny Drapkin; Paola D Vermeer
Journal:  Gynecol Oncol       Date:  2019-04-17       Impact factor: 5.482

Review 2.  Stress Hormones: Emerging Targets in Gynecological Cancers.

Authors:  Guoqiang Chen; Lei Qiu; Jinghai Gao; Jing Wang; Jianhong Dang; Lingling Li; Zhijun Jin; Xiaojun Liu
Journal:  Front Cell Dev Biol       Date:  2021-07-09

3.  Restricting the induction of NGF in ovarian stroma engenders selective follicular activation through the mTOR signaling pathway.

Authors:  Yuanlin He; Xiaoxu Peng; Tinghe Wu; Weijie Yang; Wenwen Liu; Jing Zhang; Yiping Su; Feifei Kong; Xiaowei Dou; Jing Li
Journal:  Cell Death Dis       Date:  2017-05-25       Impact factor: 8.469

Review 4.  Is the oocyte quality affected by endometriosis? A review of the literature.

Authors:  Ana Maria Sanchez; Valeria Stella Vanni; Ludovica Bartiromo; Enrico Papaleo; Eran Zilberberg; Massimo Candiani; Raoul Orvieto; Paola Viganò
Journal:  J Ovarian Res       Date:  2017-07-12       Impact factor: 4.234

Review 5.  Role of Nerve Growth Factor (NGF) and miRNAs in Epithelial Ovarian Cancer.

Authors:  Rocío Retamales-Ortega; Lorena Oróstica; Carolina Vera; Paula Cuevas; Andrea Hernández; Iván Hurtado; Margarita Vega; Carmen Romero
Journal:  Int J Mol Sci       Date:  2017-02-26       Impact factor: 5.923

6.  CUMS Promotes the Development of Premature Ovarian Insufficiency Mediated by Nerve Growth Factor and Its Receptor in Rats.

Authors:  Xiaoyan Fu; Qun Zheng; Ning Zhang; Mingxing Ding; Xiaoming Pan; Wenqian Wang; Haohao Chen
Journal:  Biomed Res Int       Date:  2020-06-30       Impact factor: 3.411

7.  Ovarian BDNF promotes survival, migration, and attachment of tumor precursors originated from p53 mutant fallopian tube epithelial cells.

Authors:  Min Kang; Kay Yi Chong; Tobias M P Hartwich; Fangfang Bi; Allyson K Witham; David Patrick; Madeline J Morrisson; Sarah L Cady; Alexandra P Cerchia; Dawn Kelk; Yifei Liu; Jonah Nucci; Oluwagbemisola Madarikan; Daiki Ueno; Brian M Shuch; Yang Yang-Hartwich
Journal:  Oncogenesis       Date:  2020-05-29       Impact factor: 7.485

Review 8.  The GDNF Family: A Role in Cancer?

Authors:  Graeme C Fielder; Teresa Wen-Shan Yang; Mahalakshmi Razdan; Yan Li; Jun Lu; Jo K Perry; Peter E Lobie; Dong-Xu Liu
Journal:  Neoplasia       Date:  2017-12-12       Impact factor: 5.715

9.  Excessive nerve growth factor impairs bidirectional communication between the oocyte and cumulus cells resulting in reduced oocyte competence.

Authors:  Yiwen Zhai; Guidong Yao; Faiza Rao; Yong Wang; Xiaoyuan Song; Fei Sun
Journal:  Reprod Biol Endocrinol       Date:  2018-03-27       Impact factor: 5.211

10.  Metformin prevents nerve growth factor-dependent proliferative and proangiogenic effects in epithelial ovarian cancer cells and endothelial cells.

Authors:  Maritza P Garrido; Carolina Vera; Margarita Vega; Andrew F G Quest; Carmen Romero
Journal:  Ther Adv Med Oncol       Date:  2018-05-04       Impact factor: 8.168

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.